Herein we describe the first synthetic efforts toward the total synthesis of isodaphlongamine H, acalyciphylline Btype alkaloid. The strategy employs achemoenzymatic process for the preparation of af unctionalizedc yclopentanol with aq uaternary center.T his molecule is elaborated to form an enantiopure 1-aza-perhydrocyclopentalene core,r epresenting rings Aa nd Eo fa ll calyciphylline B-type alkaloids.F urther transformations involve the formation of ac yclic enaminone, 1,4-conjugate addition with ac yclopentenyl subunit, and intramolecular aldol cyclization to achieveapentacyclic intermediate,u ltimately forming isodaphlongamine Hi n atotal of 24 steps from the commercially available compound 2-carbethoxycyclopentanone.I sodaphlongamine He xhibits promising inhibitory activity against ap anel of human cancer cell lines.